Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
US Army
Queensland Health

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: S-timolol hemihydrate composition and method of preparation therefor
Abstract:A novel compound and method for making and using compositions containing S--(--)-3-morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5 thiadiazole hemihydrate useful for administration to a subject particularly for topical administration as a pharmaceutical agent for treating known conditions and disorder.
Inventor(s): Per alampi; Markku (SF-36200 Kangasala, FI)
Filing Date:Oct 07, 1994
Application Number:08/319,868
Claims:1. A pharmaceutical composition for the topical application to the eye of a subject comprising S--(--) -3-morpholino-4-(3-tert-butyl-amino-2-hydroxypropoxy)-1,2,5-thiadiazole hemihydrate.

2. The composition of claim 1 wherein the composition is in a dosage form.

3. Process for making a composition for topical treatment of a subject comprising the steps of:

crystallizing S--(--)-3-morpholino-4-(3-tert-butyl-amino-2-hydroxypropoxy)-1,2,5-thiadia zole hemihydrate from an aqueous solution containing S-timolol base and at least one organic solvent;

selecting one or more pharmaceutically acceptable adjuvants for topical administration to the subject; and

admixing the selected adjuvants with the S--(--)-3-morpholino 4-(3-tert-butyl-amino-2-hydroxypropoxy)- 1,2,5-thiadiazole hemihydrate.

4. The process of claim 1 further comprising dissolving the S--(--)-3-morpholino-4-(3-tert-butyl-amino-2-hydroxypropoxy)-1,2,5-thiad iazole hemihydrate and selected adjuvants in aqueous solution.

5. The process of claim 1 further comprising forming the composition into a dosage form.

6. The process of claim 4 further comprising forming the composition into a dosage form.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Farmers Insurance
Harvard Business School
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: